# OXYGEN DEVELOPMENT, L.L.C., Palm Springs, FL – FDA Inspections

Source: https://www.keypedia.com/companies/oxygen-development-llc/024c27c1-6cfa-4c7b-9daf-9005cbf515b7

> Inspection records and compliance data for OXYGEN DEVELOPMENT, L.L.C. in Palm Springs, Florida. 8 FDA inspections on record, 2 Form 483s, last inspected May 19, 2026.

---

## Details

- Name: OXYGEN DEVELOPMENT, L.L.C.
- FEI Number: 3009461317
- Address Line 1: 1525 S Congress Ave
- City: Palm Springs
- State: Florida
- Zip Code: 33406
- Country Name: United States
- Address: 1525 S Congress Ave, Palm Springs, Florida 33406, United States
- Country: United States

## Related Documents

- FDA Inspection 1295654 - OXYGEN DEVELOPMENT, L.L.C. - 2026-05-19 — classification: No Action Indicated (NAI), source: FDA, date: May 19, 2026
- [483 - OXYGEN DEVELOPMENT, L.L.C. - 2025-09-11](https://www.keypedia.com/records/483/oxygen-development-llc/b36d2d36-735e-40c3-a882-a4a6d8fdb1ce) — source: FDA, date: September 11, 2025
- [FDA Inspection 1250745 - OXYGEN DEVELOPMENT, L.L.C. - 2025-09-11](https://www.keypedia.com/records/fda_inspections/oxygen-development-llc/951e75e0-9474-4220-8341-ba8cd5ae30a1) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 11, 2025
- [EIR - OXYGEN DEVELOPMENT, L.L.C. - 2018-01-19](https://www.keypedia.com/records/eir/oxygen-development-llc/01acffc0-62e1-48a8-bffe-1151ef309b5b) — source: FDA, date: January 19, 2018
- FDA Inspection 1042460 - OXYGEN DEVELOPMENT, L.L.C. - 2018-01-19 — classification: No Action Indicated (NAI), source: FDA, date: January 19, 2018
- [EIR - OXYGEN DEVELOPMENT, L.L.C. - 2018-01-17](https://www.keypedia.com/records/eir/oxygen-development-llc/52199a5f-bd75-44ae-95ec-33420199da2c) — source: FDA, date: January 17, 2018
- [483 - OXYGEN DEVELOPMENT, L.L.C. - 2018-01-17](https://www.keypedia.com/records/483/oxygen-development-llc/8a8320a3-2cff-4b58-955c-fef5cb2a96d1) — source: FDA, date: January 17, 2018
- [FDA Inspection 1039561 - OXYGEN DEVELOPMENT, L.L.C. - 2018-01-17](https://www.keypedia.com/records/fda_inspections/oxygen-development-llc/9deefb7a-9015-45ac-b4cf-eb9d000bd06d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 17, 2018
- [FDA Inspection 857278 - OXYGEN DEVELOPMENT, L.L.C. - 2013-11-22](https://www.keypedia.com/records/fda_inspections/oxygen-development-llc/83b1d754-fed3-4709-8a26-932a779f6a8b) — classification: No Action Indicated (NAI), source: FDA, date: November 22, 2013
- FDA Inspection 857278 - OXYGEN DEVELOPMENT, L.L.C. - 2013-11-22 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 22, 2013
- FDA Inspection 857278 - OXYGEN DEVELOPMENT, L.L.C. - 2013-11-22 — classification: No Action Indicated (NAI), source: FDA, date: November 22, 2013
- [FDA Inspection 824681 - OXYGEN DEVELOPMENT, L.L.C. - 2013-03-29](https://www.keypedia.com/records/fda_inspections/oxygen-development-llc/71aada83-67bb-4e02-ae37-670289f578ea) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 29, 2013
- FDA Inspection 824681 - OXYGEN DEVELOPMENT, L.L.C. - 2013-03-29 — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 29, 2013
- [FDA Inspection 775347 - OXYGEN DEVELOPMENT, L.L.C. - 2012-05-11](https://www.keypedia.com/records/fda_inspections/oxygen-development-llc/f1c2a2c7-8908-4fa2-bee4-d757bc3ea54d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 11, 2012

## Related Companies

- [Aphena Pharma Solutions-Maryland LLC](https://www.keypedia.com/companies/aphena-pharma-solutions-maryland-llc/97893fd6-3370-41f2-95ce-17928ab057e2)
- [PureTek Corporation](https://www.keypedia.com/companies/puretek-corporation/428846ad-3d0d-4e9e-9b5e-41321940234c)
- [Medical Products Laboratories, Inc.](https://www.keypedia.com/companies/medical-products-laboratories-inc/7e417525-325c-4b38-9007-cee432ed2387)
- [Bayer HealthCare LLC](https://www.keypedia.com/companies/bayer-healthcare-llc/1bf3da7f-9bbd-4d63-9a03-54f116b53d33)
- [Hospira, Inc.](https://www.keypedia.com/companies/hospira-inc/d4decc1e-4b42-43bb-be2c-abcefbc7b965)
- [Accra-Pac, Inc.](https://www.keypedia.com/companies/accra-pac-inc/fe89d000-bb66-4348-9b5a-2e86dd5117eb)
- [Accupac, LLC](https://www.keypedia.com/companies/accupac-llc/89921980-5d45-47e3-8098-b5700be9f082)
- [Woodstock Sterile Solutions Inc](https://www.keypedia.com/companies/woodstock-sterile-solutions-inc/c74552f5-448f-41b6-80db-4a6c566f5944)
- [The Procter & Gamble Manufacturing Company](https://www.keypedia.com/companies/the-procter-gamble-manufacturing-company/ceebac3f-c234-4225-b666-964153cdba97)
- [Sovereign Pharmaceuticals, LLC](https://www.keypedia.com/companies/sovereign-pharmaceuticals-llc/b8432227-cad1-4c55-91cc-a8c613f765fd)

## Related Officers

- [Jennifer L. Huntington](https://www.keypedia.com/people/jennifer-l-huntington/c04e1c86-c7ec-4613-b3f7-a1f9ba2b2f2c)
- [company_representative](https://www.keypedia.com/people/linda-fundo/12a96a3e-8493-44de-8feb-9b9a9139045f)
- [issuing_officer](https://www.keypedia.com/people/frances-m-rivera-rosario/23aa886e-b113-4366-97f2-5bd719d60a41)
